Cargando…

Co‐diagnoses of acute myeloid leukaemia and COVID‐19: presentation and management implications

We report a case of concurrent new diagnoses of confirmed severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and acute myeloid leukaemia (AML). We review the existing literature on coronavirus disease 2019 (COVID‐19) in the immunocompromised patient and the implications for manag...

Descripción completa

Detalles Bibliográficos
Autores principales:	O'Brien, Amy, Campling, James, Goodman, Hugh, Chang, Catherina L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445738/ https://www.ncbi.nlm.nih.gov/pubmed/32864140 http://dx.doi.org/10.1002/rcr2.650

Ejemplares similares

Acute Myeloid Leukaemia Presenting as Gaze Palsy
por: Sykakis, Evripidis, et al.
Publicado: (2011)

Prognostic Parameters of Acute Myeloid Leukaemia at Presentation
por: Jahic, Azra, et al.
Publicado: (2017)

The UK SPIRIT 1 trial in newly-diagnosed chronic myeloid leukaemia (CML)
por: Gallipoli, Paolo, et al.
Publicado: (2022)

Acute myeloid leukaemia relapse presenting as cardiac myeloid sarcoma
por: Waselewski, Alexander, et al.
Publicado: (2018)

Phlegmonous gastritis as the initial presentation of acute myeloid leukaemia
por: Lee, Shin, et al.
Publicado: (2022)

Immunophenotypic characterisation of morphologically diagnosed cases of Acute Myeloid Leukaemia (AML)
por: Basharat, Maria, et al.
Publicado: (2019)

Unilateral nasal obstruction: a rare presentation of acute myeloid leukaemia
por: Kelly, Mairead, et al.
Publicado: (2021)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

Acute Myeloid Leukemia: Advanced Practice Management From Presentation to Cure
por: Beaton, Meredith, et al.
Publicado: (2020)

Unfavourable clinical implications for HLA-G expression in acute myeloid leukaemia
por: Yan, W-H, et al.
Publicado: (2008)

Two ophthalmic presentations of chronic myeloid leukaemia
por: Kiernan, Miles, et al.
Publicado: (2022)

Targeting apoptosis in acute myeloid leukaemia
por: Cassier, Philippe A, et al.
Publicado: (2017)

Adhesion Deregulation in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Murine Models of Acute Myeloid Leukaemia
por: Almosailleakh, Marwa, et al.
Publicado: (2019)

Wnt Signalling in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Targeting β-catenin in acute myeloid leukaemia: past, present, and future perspectives
por: Wagstaff, Megan, et al.
Publicado: (2022)

IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia
por: Kuett, Alexander, et al.
Publicado: (2015)

Acute myeloid leukaemia presenting as acute liver failure—a case report and literature review
por: Sun, Kai, et al.
Publicado: (2019)

Proceedings: Active immunotherapy in acute myeloid leukaemia.
por: Freeman, C. B., et al.
Publicado: (1975)

Rarity of microsatellite alterations in acute myeloid leukaemia.
por: Sill, H., et al.
Publicado: (1996)

'Lot's Wife' Syndrome in Acute Myeloid Leukaemia
por: Barnett, M. M.
Publicado: (1984)

Acute Myeloid Leukaemia: New Targets and Therapies
por: Brown, Geoffrey, et al.
Publicado: (2017)

Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia
por: Khan, Ghazala Naz, et al.
Publicado: (2019)

Targeting Apoptotic Pathways in Acute Myeloid Leukaemia
por: Sillar, Jonathan R., et al.
Publicado: (2019)

Acute myeloid leukaemia presenting with ecthyma gangrenosum as the first manifestation: A case report
por: Hadano, Yoshiro, et al.
Publicado: (2021)

The Prognostic Significance of C-Reactive Protein to Albumin Ratio in Newly Diagnosed Acute Myeloid Leukaemia Patients
por: Dou, Liurui, et al.
Publicado: (2022)

Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia
por: Poudel, Govinda, et al.
Publicado: (2022)

Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980)

Prediction of acute myeloid leukaemia risk in healthy individuals
por: Abelson, Sagi, et al.
Publicado: (2018)

MicroRNA-150 down Regulation in Acute Myeloid Leukaemia Patients and Its Prognostic Implication
por: Abdelhalim, Dalia A., et al.
Publicado: (2018)

Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy
por: Iluta, Sabina, et al.
Publicado: (2021)

Immunotherapy of acute myeloid leukaemia. Medical Research Council.
Publicado: (1978)

Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups
por: Moorman, A V, et al.
Publicado: (2002)

MicroRNAs: new players in acute myeloid leukaemia
por: Havelange, V, et al.
Publicado: (2009)

The rocky road to personalized medicine in acute myeloid leukaemia
por: Brinda, Bryan, et al.
Publicado: (2018)

N6-Methyladenosine Role in Acute Myeloid Leukaemia
por: Ianniello, Zaira, et al.
Publicado: (2018)

SRC-Family Kinases in Acute Myeloid Leukaemia and Mastocytosis
por: Voisset, Edwige, et al.
Publicado: (2020)

The power and potential of integrated diagnostics in acute myeloid leukaemia
por: Haferlach, Torsten, et al.
Publicado: (2019)

Isolated CNS leukaemic relapse in acute myeloid leukaemia
por: Essa, Amr, et al.
Publicado: (2019)

The Role of Reactive Oxygen Species in Acute Myeloid Leukaemia
por: Sillar, Jonathan R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f2dmce800tnd64gvtsng0es5cm